{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:06Z","timestamp":1792511526024,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA006516"],"award-info":[{"award-number":["P30CA006516"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["123420RSG-12-224-01-DMC"],"award-info":[{"award-number":["123420RSG-12-224-01-DMC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2P50CA127003-06A1"],"award-info":[{"award-number":["2P50CA127003-06A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jnci\/djx031","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T15:09:48Z","timestamp":1494947388000},"source":"Crossref","is-referenced-by-count":117,"title":["Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype"],"prefix":"10.1093","volume":"109","author":[{"given":"Theodore S.","family":"Hong","sequence":"first","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell R.","family":"Borger","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beow Y.","family":"Yeap","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin I.","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Willers","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Blaszkowsky","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice L.","family":"Kwak","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill N.","family":"Allen","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Clark","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Tanguturi","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Goyal","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Wolfgang","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine C.","family":"Drapek","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Arellano","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Mamon","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Mullen","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"DeLaney","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[{"name":"Affiliations of Authors: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD, TFD), Department of Pathology (DRB, AJI), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology, Department of Medicine (LSB, ELK, JNA, JWC, LG, JEM, DPR, AXZ), Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"issue":"8","key":"key\n\t\t\t\t20180328133401_djx031-B1","first-page":"3381","article-title":"Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: Preliminary results","volume":"29","author":"Ambrosino","year":"2009","journal-title":"Anticancer Res."},{"issue":"2","key":"key\n\t\t\t\t20180328133401_djx031-B2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","article-title":"Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I\/II trial","volume":"19","author":"Herfarth","year":"2001","journal-title":"J Clin Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180328133401_djx031-B4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol."},{"issue":"10","key":"key\n\t\t\t\t20180328133401_djx031-B5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180328133401_djx031-B6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study","volume":"45","author":"Mendez Romero","year":"2006","journal-title":"Acta Oncol."},{"issue":"10","key":"key\n\t\t\t\t20180328133401_djx031-B7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol."},{"issue":"2","key":"key\n\t\t\t\t20180328133401_djx031-B8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2012.12.021","article-title":"Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial","volume":"86","author":"Scorsetti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"key\n\t\t\t\t20180328133401_djx031-B9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.prro.2013.10.002","article-title":"A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors","volume":"4","author":"Hong","year":"2014","journal-title":"Pract Radiat Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180328133401_djx031-B10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.prro.2015.01.004","article-title":"Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons","volume":"5","author":"Gandhi","year":"2015","journal-title":"Pract Radiat Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180328133401_djx031-B11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/1541-7786.MCR-14-0570","article-title":"Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers","volume":"13","author":"Liu","year":"2015","journal-title":"Mol Cancer Res."},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cllc.2014.09.005","article-title":"Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer","volume":"16","author":"Mak","year":"2015","journal-title":"Clin Lung Cancer."},{"issue":"20","key":"key\n\t\t\t\t20180328133401_djx031-B13","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/0008-5472.CAN-13-1616","article-title":"Integrative radiogenomic profiling of squamous cell lung cancer","volume":"73","author":"Abazeed","year":"2013","journal-title":"Cancer Res."},{"issue":"23","key":"key\n\t\t\t\t20180328133401_djx031-B14","first-page":"6597","article-title":"Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines","volume":"60","author":"Bernhard","year":"2000","journal-title":"Cancer Res."},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B15","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2014.05.511","article-title":"Integrative radiogenomic profiling identifies BRAF mutations as novel radiotherapeutic targets in adenocarcinomas of the lung","volume":"90","author":"Hearn","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-16-0127","article-title":"Role of KEAP1\/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance","volume":"7","author":"Jeong","year":"2016","journal-title":"Cancer Discov."},{"issue":"2","key":"key\n\t\t\t\t20180328133401_djx031-B17","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.2214\/AJR.14.12901","article-title":"CT-guided implantation of intrahepatic fiducial markers for proton beam therapy of liver lesions: Assessment of success rate and complications","volume":"204","author":"Kulkarni","year":"2015","journal-title":"Am J Roentgenol."},{"issue":"5","key":"key\n\t\t\t\t20180328133401_djx031-B18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/emmm.201000070","article-title":"Rapid targeted mutational analysis of human tumours: A clinical platform to guide personalized cancer medicine","volume":"2","author":"Dias-Santagata","year":"2010","journal-title":"EMBO Mol Med."},{"key":"key\n\t\t\t\t20180328133401_djx031-B19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20180328133401_djx031-B20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1593\/neo.06823","article-title":"Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells","volume":"9","author":"Cengel","year":"2007","journal-title":"Neoplasia."},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12029-013-9546-y","article-title":"Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer","volume":"45","author":"Russo","year":"2014","journal-title":"J Gastrointest Cancer."},{"issue":"3","key":"key\n\t\t\t\t20180328133401_djx031-B22","doi-asserted-by":"crossref","first-page":"486\u2013492","DOI":"10.1097\/SLA.0b013e31822b8cfa","article-title":"Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg."},{"issue":"8","key":"key\n\t\t\t\t20180328133401_djx031-B23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov."},{"issue":"3\u20134","key":"key\n\t\t\t\t20180328133401_djx031-B24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/B:CANC.0000031764.81141.e4","article-title":"The p53 protein family and radiation sensitivity: Yes or no?","volume":"23","author":"Cuddihy","year":"2004","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"key\n\t\t\t\t20180328133401_djx031-B25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09553000801953342","article-title":"A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status","volume":"84","author":"Williams","year":"2008","journal-title":"Int J Radiat Biol."},{"issue":"10","key":"key\n\t\t\t\t20180328133401_djx031-B26","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.onc.1208396","article-title":"Nonhomologous end-joining of site-specific but not of radiation-induced DNA double-strand breaks is reduced in the presence of wild-type p53","volume":"24","author":"Dahm-Daphi","year":"2005","journal-title":"Oncogene."},{"issue":"1","key":"key\n\t\t\t\t20180328133401_djx031-B27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-11-2260","article-title":"TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence","volume":"18","author":"Skinner","year":"2012","journal-title":"Clin Cancer Res."},{"issue":"8","key":"key\n\t\t\t\t20180328133401_djx031-B28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/cdd.2015.53","article-title":"TP53: An oncogene in disguise","volume":"22","author":"Soussi","year":"2015","journal-title":"Cell Death Differ."},{"issue":"10","key":"key\n\t\t\t\t20180328133401_djx031-B29","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/0008-5472.CAN-13-3157","article-title":"EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"issue":"12","key":"key\n\t\t\t\t20180328133401_djx031-B30","doi-asserted-by":"crossref","first-page":"e82982","DOI":"10.1371\/journal.pone.0082982","article-title":"Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers","volume":"8","author":"Kleiman","year":"2013","journal-title":"PLoS One."},{"issue":"5","key":"key\n\t\t\t\t20180328133401_djx031-B31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","article-title":"Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy","volume":"92","author":"Binkley","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"key\n\t\t\t\t20180328133401_djx031-B32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/pme.12.55","article-title":"A molecular assay of tumor radiosensitivity: A roadmap towards biology-based personalized radiation therapy","volume":"9","author":"Torres-Roca","year":"2012","journal-title":"Per Med."},{"key":"key\n\t\t\t\t20180328133401_djx031-B33","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ijrobp.2014.05.188","article-title":"Local control following stereotactic body radiotherapy for liver tumors: A preliminary report of the AAPM Working Group for SBRT","volume":"90","author":"Ohri","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/109\/9\/djx031\/24368530\/djx031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T14:35:23Z","timestamp":1522247723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/doi\/10.1093\/jnci\/djx031\/3852626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,5,25]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx031","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,1]]},"published":{"date-parts":[[2017,5,25]]}}}